Orit Itzhaki Selected Research

Orit Itzhaki Research Topics

Disease

29	Neoplasms (Cancer) 01/2024 - 03/2004
26	Melanoma (Melanoma, Malignant) 01/2023 - 03/2006
5	Experimental Melanoma 01/2009 - 03/2004
4	Lymphoma (Lymphomas) 01/2009 - 03/2004
3	Leukemia 05/2024 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 12/2018
2	Clinical Deterioration 09/2019 - 05/2009
1	cell-associated neurotoxicity 08/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2022
1	Disease Progression 12/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Neutropenia 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Adenocarcinoma 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Pathologic Processes 04/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2009
1	Tetraploidy 03/2008

Drug/Important Bio-Agent (IBA)

13	Chimeric Antigen ReceptorsIBA 08/2023 - 01/2013
4	MicroRNAs (MicroRNA)IBA 06/2021 - 04/2011
4	Interleukin-2 (IL2)IBA 09/2013 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 09/2013
2	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 09/2023
2	Galactose (Galactopyranose)FDA LinkGeneric 05/2024 - 09/2023
2	Messenger RNA (mRNA)IBA 02/2019 - 11/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017 - 01/2013
2	Levamisole (Decaris)FDA Link 01/2009 - 07/2004
2	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 01/2009 - 04/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2009 - 03/2004
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2009 - 03/2004
2	Immunologic Factors (Immunomodulators)IBA 01/2009 - 07/2004
1	CytokinesIBA 08/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	tisagenlecleucelIBA 12/2022
1	fludarabineIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	CD19 AntigensIBA 01/2020
1	ParaffinIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Zoledronic Acid (Zometa)FDA Link 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	InterferonsIBA 02/2019
1	AntigensIBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	EpitopesIBA 01/2017
1	EnzymesIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	Adenosine DeaminaseIBA 10/2015
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2015
1	IpilimumabIBA 10/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	Transforming Growth Factor-beta Type II ReceptorIBA 06/2014
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2013
1	Hormones (Hormone)IBA 11/2011
1	Interferon-gamma (Interferon, gamma)IBA 05/2009
1	DNA (Deoxyribonucleic Acid)IBA 03/2008
1	Angiogenesis InhibitorsIBA 04/2006
1	hydrocortisone acetate (Cortifoam)FDA LinkGeneric 03/2004

Therapy/Procedure

21	Therapeutics 01/2024 - 03/2004
12	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 03/2006
11	Immunotherapy 01/2023 - 07/2004
4	Drug Therapy (Chemotherapy) 11/2011 - 03/2006
3	Salvage Therapy 12/2022 - 01/2020
1	Injections 01/2020
1	Tissue and Organ Harvesting 09/2019
1	Prostatectomy (Retropubic Prostatectomy) 01/2019
1	Aftercare (After-Treatment) 01/2013